Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are Investors Losing Confidence in These 5 Stocks Today?

It’s a rather flat day on Wall Street, as all three major indexes are hovering around level ground for the day. The Dow Jones is up by just seven points while the S&P 500 is down by a single point. While the broader market is flat, shares of Argos Therapeutics Inc (NASDAQ:ARGS), CalAmp Corp. (NASDAQ:CAMP), Alere Inc (NYSE:ALR), Clean Energy Fuels Corp (NASDAQ:CLNE), and Yum! Brands, Inc. (NYSE:YUM) are not so lucky, as all five stocks are in the red this morning. Let’s find out what is going on with these five stocks and see what the smart money in our database collectively thinks of each of them.

Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

Argos COO to Resign

Argos Therapeutics Inc (NASDAQ:ARGS) shares are 24% in the red today after the company filed a report with the SEC announcing that its COO, Fred Miesowicz, will resign on April 22. In the same report, Argos announced that it will cut its workforce by 13% or 18 employees to reduce operating expenses by approximately $2.3 million a year. Argos’ lead drug candidate is AGS-003, which is in Phase III trials for the possible treatment of metastatic renal cell carcinoma. Of the 786 elite funds Insider Monkey tracks, two of them were long the stock, owning slightly over half-a-million dollars worth of Argos Therapeutics Inc (NASDAQ:ARGS)’s shares between them at the end of 2015.

CalAmp Lower on Earnings

CalAmp Corp. (NASDAQ:CAMP) has fallen by 13% in late morning trading after the company reported disappointing earnings for its fourth quarter of fiscal year 2016. For the fiscal period, CalAmp earned $0.32 per share on revenue of $70.8 million, meeting earnings estimates but falling short of top-line expectations by $0.25 million. Revenue from the company’s wireless datacom segment inched down by 2.6% year-over-year while adjusted EBITDA came in at $13.7 million. For the first quarter of fiscal year 2017, CalAmp anticipates consolidated revenue from continuing operations of $77 million-to-$85 million. Jim Simons‘ Renaissance Technologies owned 133,800 shares of CalAmp Corp. (NASDAQ:CAMP) at the end of 2015.

Follow Calamp Corp. (NASDAQ:CAMP)
Trade (NASDAQ:CAMP) Now!

On the next page, we examine why Alere Inc, Clean Energy Fuels Corp, and Yum! Brands Inc. are all treading water today.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.